Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Adolescents treated for obesity with GLP-1 drugs had lower risk of suicidal thoughts, study finds
A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 medications semaglutide or liraglutide were less likely to have suicidal thoughts or attempts than those treated with behavioral interventions.
Study: GLP-1 weight-loss drugs might lower, not increase, teen suicide risk
In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and suicide attempts compared to adolescents who didn't.
GLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs Boom
The future of the weight loss market might not revolve around GLP-1 drugs.
GLP-1 Receptor Agonists Reduce Suicidal Behavior in Adolescents With Obesity
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third decreased risk for suicidal ideation and suicide attempts compared with lifestyle intervention alone, a large international retrospective study found.
Not Many Employers Cover GLP-1 Weight Loss Drugs
Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.
Suicidal Thoughts Less Likely in Youths on Weight Loss Drugs
It may not sound surprising that treating obesity in adolescents and teens may have positive mental health impacts, but researchers this week reported reassuring findings about whether popular new injectable weight loss medicines carry mental health risks.
Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With Obesity
For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduced risk for suicidal ideation or attempts, according to a study published online Oct.
Study says Ozempic may reduce the risk of suicide in obese teens
The first country album to go platinum came out almost 50 years ago. See what it was, and look back on more country music milestones. 'It's not taxed at all': Warren Buffett shared the 'best investment' you can make when battling inflation — here are a few ways to put it into action Trump Pennsylvania Event Derailed After Audience Faintings 23 Certifications That Are Actually Easy To Get If You Want A High Paying Job Potential Tropical Storm Nadine Spaghetti Models Show Chances Of Hitting Florida Why do dogs sleep so much?
Weight loss drugs may help obese teens have less suicidal thoughts, study finds
A new study found that obese teens prescribed with weight loss drugs are less likely to have suicidal thoughts.
11h
on MSN
‘GLP-1’ Has Lost All Meaning
Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic. If you had come across the ...
News Medical
8m
Expanding access to GLP-1 weight-loss drugs could save thousands of lives
Researchers estimate that expanding access to weight-loss drugs could save over 50,000 lives annually, reducing obesity rates ...
6h
Diabetes, high BMI, previous metformin prescriptions are common in teens with prescriptions for GLP-1 RAs
Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...
Medpage Today on MSN
2d
Study Suggests No Suicide Signal in Teens Prescribed GLP-1 Agonists
Treatment with GLP-1 receptor agonists was associated with lower risks of suicidal ideation or attempts in adolescents with ...
Medical News Today
5d
GLP-1 drugs like Ozempic may protect brain health, several studies show
A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...
6d
The Crackdown on Compounded GLP-1 Meds Has Begun
Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...
2d
LifeVantage Introduces the MindBody GLP-1 System™ Transforming Weight Management into a Sustainable Lifestyle
Met With High Demand, the Dual-Product System is Clinically Shown to Increase GLP-1 by 140% on average to Balance Hunger ...
News Medical on MSN
1d
Dietitians boost GLP-1 therapy success with personalized care and side effect management
Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Food and Drug Administration
Zepbound
Novo Nordisk
Wegovy
Glucagon-like peptide-1
Feedback